Delivery Order SPE2DB20D3103-SPE2DB25FM7N3
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,235.47 firm-fixed-price contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a prescription medication, with a period of performance ending on November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,996.61 firm fixed-price contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a period of performance ending on January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,239.12 delivery order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order that will run through February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price agreement with a ceiling value of $2,506.36 and a period of performance through November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The contract has a ceiling value of $25,231.85 and a completion date of September 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen has been awarded multiple federal contracts by various agencies, including an Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,464.55 Firm Fixed Price Delivery Order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a prescription drug product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The $4,126.85 firm fixed-price contract has a completion date of June 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,120.02 Firm Fixed Price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,207.24 firm fixed-price contract is for XIFAXAN 550 MG Tablet 60s, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Delivery Order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,924.06 firm fixed-price contract is for the delivery of XIFAXAN 550 MG TABLET 60S, with a completion date of February 21, 2024. Amerisourcebergen, a for-profit pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a...